Seer, Inc. (SEER)
- Previous Close
1.7500 - Open
1.7300 - Bid 1.6600 x 100
- Ask 1.7200 x 100
- Day's Range
1.6400 - 1.7399 - 52 Week Range
1.4550 - 5.6500 - Volume
665,371 - Avg. Volume
467,744 - Market Cap (intraday)
107.524M - Beta (5Y Monthly) 1.65
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3500 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.00
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
seer.bioRecent News: SEER
Performance Overview: SEER
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SEER
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SEER
Valuation Measures
Market Cap
107.52M
Enterprise Value
-180.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.98
Price/Book (mrq)
0.27
Enterprise Value/Revenue
-11.89
Enterprise Value/EBITDA
1.84
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-13.99%
Return on Equity (ttm)
-20.45%
Revenue (ttm)
16.66M
Net Income Avi to Common (ttm)
-86.28M
Diluted EPS (ttm)
-1.3500
Balance Sheet and Cash Flow
Total Cash (mrq)
316.22M
Total Debt/Equity (mrq)
7.12%
Levered Free Cash Flow (ttm)
-32.33M
Research Analysis: SEER
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell